We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio The FDA has set a new target action date ...

Please provide your email address to receive an email when new articles are posted on . The FDA has extended the prescription drug user fee act target action date for the new drug application for ...

A committee of the Food and Drug Administration's outside advisers voted Thursday in favor of an epinephrine nasal spray product, clearing a key hurdle for what could soon be the first needle-free ...

Epinephrine nasal spray works well even if patients sniff while using it, according to an abstract presented at the American College of Allergy, Asthma, and Immunology (ACAAI) 2025 Annual Meeting in ...

The US Food and Drug Administration on Tuesday did not approve a needle-free epinephrine for treatment of severe allergic reactions, a move that drugmaker ARS Pharmaceuticals called surprising.

The designation is supported by data from Part 1 of the EPIPHAST study, which compared the pharmacokinetics and pharmacodynamics of AQST-109 to intramuscular epinephrine in healthy adults. The Food ...

A multicenter study found that a 2-hour monitoring period was sufficient for most children who presented to the emergency department with an acute allergic reaction treated with epinephrine. However, ...

A timely injection of epinephrine can save the life of a person experiencing an allergic reaction. But what if the syringe is jammed? Now, a U.S. company is recalling its version of the critical ...